Anxiety disorder induced by multiple specified psychoactive substances (Q40961): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Transtorno de ansiedade induzido por múltiplas substâncias psicoativas especificadas é caracterizado por sintomas ansiosos (p. ex., apreensão ou preocupação, medo, sintomas fisiológicos de ativação autonômica excessiva, comportamento de evitação) que se desenvolvem durante ou logo após intoxicação por ou abstinência de múltiplas substâncias psicoativas especificadas. A intensidade ou duração dos sintomas é consideravelmente maior do que sintomas ansiosos característicos da intoxicação por ou abstinência de múltiplas substâncias psicoativas especificadas. A quantidade e duração do uso das múltiplas substâncias psicoativas especificadas devem ser capazes de produzir sintomas de ansiedade. Os sintomas não são mais bem explicados por um transtorno mental primário (p.ex., transtorno de ansiedade e relacionado ao medo, transtorno depressivo com sintomas ansiosos proeminentes), como pode ser o caso se os sintomas de ansiedade precederam o início do uso de múltiplas substâncias psicoativas especificadas, se os sintomas persistem por um período de tempo considerável após a cessação do uso das múltiplas substâncias psicoativas especificadas ou a abstinência das múltiplas substâncias psicoativas especificadas, ou se há outra evidência de um transtorno mental primário preexistente com sintomas ansiosos (p. ex., história de episódios anteriores não associados ao uso das múltiplas substâncias psicoativas especificadas). | |||
| description / en | description / en | ||
Anxiety disorder induced by multiple specified psychoactive substances is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxication with or withdrawal from multiple specified psychoactive substances. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of intoxication with or withdrawal from multiple specified psychoactive substances. The amount and duration of use of the multiple specified psychoactive substances must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the use of the multiple specified psychoactive substances, if the symptoms persist for a substantial period of time after cessation of the use of the multiple specified psychoactive substances or withdrawal from the multiple specified psychoactive substances, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with the use of the multiple specified psychoactive substances). | |||
Revision as of 06:59, 13 August 2026
Anxiety disorder induced by multiple specified psychoactive substances is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxication with or withdrawal from multiple specified psychoactive substances. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of intoxication with or withdrawal from multiple specified psychoactive substances. The amount and duration of use of the multiple specified psychoactive substances must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the use of the multiple specified psychoactive substances, if the symptoms persist for a substantial period of time after cessation of the use of the multiple specified psychoactive substances or withdrawal from the multiple specified psychoactive substances, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with the use of the multiple specified psychoactive substances).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 6C4F.71 |
||
| English | Anxiety disorder induced by multiple specified psychoactive substances |
Anxiety disorder induced by multiple specified psychoactive substances is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxication with or withdrawal from multiple specified psychoactive substances. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of intoxication with or withdrawal from multiple specified psychoactive substances. The amount and duration of use of the multiple specified psychoactive substances must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the use of the multiple specified psychoactive substances, if the symptoms persist for a substantial period of time after cessation of the use of the multiple specified psychoactive substances or withdrawal from the multiple specified psychoactive substances, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with the use of the multiple specified psychoactive substances). |
